Surgical Film Library-MIS Interval Debulking

Video Transcription

Video Summary

The presentation discusses minimally invasive surgery (MIS) for interval debulking in advanced ovarian cancer patients after neoadjuvant chemotherapy, emphasizing the importance of careful entry, exploration, and resection to avoid leaving residual disease. A video demonstrates techniques including omentectomy and lymph node dissection. The speaker introduces the upcoming LANS trial, an international phase 3 randomized control study comparing MIS versus open surgery in patients with normalized CA-125 and good chemotherapy response. The pilot phase aims to confirm feasibility, conversion rates under 25%, and comparable residual disease rates. The trial seeks to enroll 580 patients across multiple centers, focusing on disease-free survival and surgical outcomes.

Asset Subtitle

Jose Alejandro Rauh-Hain, United States

Meta Tag

Procedure Type Cytoreductive surgery

Route Open

Skill Level Expert

Surgical Location Mid-abdomen

Keywords

Open

Mid-abdomen

Expert

Cytoreductive surgery

minimally invasive surgery

interval debulking

advanced ovarian cancer

LANS trial

neoadjuvant chemotherapy